Publikasi Scopus 2024 per tanggal 30 September 2024 (820 artikel)

Sari R.F.; Fadilah F.; Maladan Y.; Sarassari R.; Safari D.
Sari, Ratna Fathma (58918622800); Fadilah, Fadilah (56966708600); Maladan, Yustinus (57204842592); Sarassari, Rosantia (57204038282); Safari, Dodi (23493586700)
58918622800; 56966708600; 57204842592; 57204038282; 23493586700
A narrative review of genomic characteristics, serotype, immunogenicity, and vaccine development of Streptococcus pneumoniae capsular polysaccharide
2024
Clinical and Experimental Vaccine Research
13
2
91
104
13
1
Master’s Programme in Biomedical Sciences, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Eijkman Research Center for Molecular Biology, National Research and Innovation Agency, Cibinong, Indonesia; Medical Chemistry Department, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia
Sari R.F., Master’s Programme in Biomedical Sciences, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia, Eijkman Research Center for Molecular Biology, National Research and Innovation Agency, Cibinong, Indonesia; Fadilah F., Medical Chemistry Department, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Maladan Y., Eijkman Research Center for Molecular Biology, National Research and Innovation Agency, Cibinong, Indonesia; Sarassari R., Eijkman Research Center for Molecular Biology, National Research and Innovation Agency, Cibinong, Indonesia; Safari D., Eijkman Research Center for Molecular Biology, National Research and Innovation Agency, Cibinong, Indonesia
This narrative review describes genomic characteristic, serotyping, immunogenicity, and vaccine development of Streptococcus pneumoniae capsular polysaccharide (CPS). CPS is a primary virulence factor of S. pneumoniae. The genomic characteristics of S. pneumoniae CPS, including the role of biosynthetic gene and genetic variation within cps (capsule poly-saccharide) locus which may lead to serotype replacement are still being investigated. One hundred unique serotypes of S. pneumoniae have been identified through various methods of serotyping using phenotypic and genotypic approach. The advantages and limitations of each method are various, emphasizing the need for accurate and comprehensive serotyping for effective disease surveillance and vaccine targeting. In addition, we elaborate the critical role of CPS in vaccine development by providing an overview of immunogenicity, ongoing research of pneumococcal vaccines, and the impact on disease burden. © 2024, Korean Vaccine Society. All rights reserved.
Capsular polysaccharide; Immunogenic-ity; Serotyping; Streptococcus pneumoniae; Vaccine development
Pneumococcus vaccine; polysaccharide; bacterial genome; disease burden; disease surveillance; genetic variation; nonhuman; pathogenesis; regulator gene; Review; serotype; serotyping; Streptococcus pneumoniae; vaccine immunogenicity
Korean Vaccine Society
22873651
Review
Q3
359
14054